Results 141 to 150 of about 2,166,017 (392)

Activated lymphocyte recruitment into the tumor microenvironment following preoperative sipuleucel-T for localized prostate cancer. [PDF]

open access: yes, 2014
BackgroundSipuleucel-T is a US Food and Drug Administration-approved immunotherapy for asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC). Its mechanism of action is not fully understood.
Amling, Christopher L   +12 more
core   +2 more sources

Magnesium Structure‐Function Integration Platform for Spatiotemporal Multi‐Modality Therapy: Combining Hormonotherapy and Immunotherapy in Prostate Cancer

open access: yesAdvanced Science, EarlyView.
The schematic illustration of the MHSCG platform for spatiotemporal responsive GRb1 release to induce androgen deprivation therapy (ADT) and immunogenic cell death (ICD) multimodal therapy in prostate cancer. Abstract Metal‐based immunotherapy represents a promising strategy for enhancing antitumor efficacy; however, its clinical application is limited
Rui Zan   +13 more
wiley   +1 more source

Myostatin inhibition with orally administered Lactobacillus casei expressing a modified human myostatin protein: functional benefits and translational potential in advanced Duchenne muscular dystrophy

open access: yesFrontiers in Neurology
BackgroundDuchenne muscular dystrophy (DMD) is a progressive neuromuscular disorder that requires novel therapeutic approaches beyond dystrophin restoration.
Jiwon Lee   +5 more
doaj   +1 more source

Study of induction of Tolerance to Oral Peanut: a randomised controlled trial of desensitisation using peanut oral immunotherapy in children (STOP II)

open access: yesEfficacy and Mechanism Evaluation, 2014
Background: Peanut allergy is a common disease that causes severe and fatal food allergic reactions. Currently, the best treatment is avoidance as repeated reactions can occur.
Katherine Anagnostou   +8 more
doaj   +1 more source

Oral Immunotherapy and Basophil and Mast Cell Reactivity in Food Allergy [PDF]

open access: gold, 2020
Anuya Paranjape   +8 more
openalex   +1 more source

Treatment of food allergy: oral immunotherapy, biologics and beyond.

open access: yesAnnals of Allergy, Asthma & Immunology, 2023
S. Sindher   +4 more
semanticscholar   +1 more source

Targeting Lactate and Lactylation in Cancer Metabolism and Immunotherapy

open access: yesAdvanced Science, EarlyView.
Lactate, once deemed a metabolic waste, emerges as a central regulator of cancer progression. This review elucidates how lactate and its epigenetic derivative, protein lactylation, orchestrate tumor metabolism, immune suppression, and therapeutic resistance.
Jiajing Gong   +5 more
wiley   +1 more source

Exploring the current potential of immunotherapeutic-based treatment approaches for the management of oral cancer: An updated review

open access: yesOral Oncology Reports
One of the most prevalent cancers of the head and neck, oral cancer may seriously hinder eating, represent a danger to life, and impair appearance. The three primary clinical therapies for oral cancer are chemotherapy, radiation, and surgery.
Abin V. Geevarghese, R. Gopika
doaj   +1 more source

Remembering the forgotten child: the role of immune checkpoint inhibition in patients with human immunod eficiency virus and cancer. [PDF]

open access: yes, 2019
Patients with human immunodeficiency virus (HIV) infection have a high risk of developing virally-mediated cancers. These tumors have several features that could make them vulnerable to immune checkpoint inhibitors (ICIs) including, but not limited to ...
Adashek, Jacob J   +3 more
core  

Supplementary Figures from Genomic and Transcriptomic Landscape of an Oral Squamous Cell Carcinoma Mouse Model for Immunotherapy

open access: gold, 2023
Yi‐Mei Lee   +5 more
openalex   +1 more source

Home - About - Disclaimer - Privacy